Trade Trends of gkdis pharma

from Jan 2022 to Jul 2025
Shipments Imported: 2
As Buyer Trade Value (USD): $4.57 K
Shipments Exported: 0
As Supplier Trade Value (USD): $0

Import and Export shipments of "gkdis pharma"

As Buyer
Consignee NameShipper NameHS CodeProduct KeywordsShipment Date
300490
HUMAN MEDICINE Ivymax Plus Syrup QTY UNITS) 5 000 Batch No. ND-25-006 Mfg. Date Jun/25 Exp. Date Jun/27 Pack Size 120ml NOC#A-3179732928759.DTD.08-07-2025.AS PER INVOICE.
Jul 15, 2025
gkdis pharma
m/s don valley pharmaceuticals pvt ltd
300490
HUMAN MEDICINE Ivymax Plus Syrup QTY UNITS) 5 000 Batch No. ND-25-006 Mfg. Date Jun/25 Exp. Date Jun/27 Pack Size 120ml NOC#A-3179732928759.DTD.08-07-2025.AS PER INVOICE.
Jul 15, 2025
gkdis pharma
m/s don valley pharmaceuticals pvt ltd
300490
HUMAN MEDICINE Ivymax Plus Syrup QTY UNITS) 5 000 Batch No. ND-25-006 Mfg. Date Jun/25 Exp. Date Jun/27 Pack Size 120ml NOC#A-3179732928759.DTD.08-07-2025.AS PER INVOICE.
Jul 15, 2025
gkdis pharma
m/s don valley pharmaceuticals pvt ltd
300490
HUMAN MEDICINE Ivymax Plus Syrup QTY UNITS) 5 000 Batch No. ND-25-006 Mfg. Date Jun/25 Exp. Date Jun/27 Pack Size 120ml NOC#A-3179732928759.DTD.08-07-2025.AS PER INVOICE.
Jul 15, 2025
gkdis pharma
m/s don valley pharmaceuticals pvt ltd
300490
HUMAN MEDICINE Ivymax Plus Syrup QTY UNITS) 5 000 Batch No. ND-25-006 Mfg. Date Jun/25 Exp. Date Jun/27 Pack Size 120ml NOC#A-3179732928759.DTD.08-07-2025.AS PER INVOICE.
Jul 15, 2025
Premium Content Locked

Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.

Trading Partners of gkdis pharma

Top Companies "gkdis pharma" is importing from (by Value USD)

Markets in which gkdis pharma trades

Top Countries "gkdis pharma" is importing from (by Value USD)

Exporting Country2025
country flagspakistan
4.57 K

Products/HS Codes traded by gkdis pharma

Top HS Codes Imported by "gkdis pharma"

USD 4.57 K | 100.00%

Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other

Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Subscribe to Intel Now→

Similar Companies to gkdis pharma

Other Buyers and Suppliers in mauritania who deal in similar products like gkdis pharma